JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

Smith & Nephew PLC ADR

Cerrado

31.94 -2.44

Resumen

Variación precio

24h

Actual

Mínimo

31.74

Máximo

32.75

Métricas clave

By Trading Economics

Ingresos

35M

331M

Ventas

203M

3.2B

P/B

Media del Sector

23.923

60.328

Rentabilidad por dividendo

2.29

Margen de beneficios

10.368

Empleados

16,988

EBITDA

133M

856M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+6.9% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.29%

2.24%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-578M

15B

Apertura anterior

34.38

Cierre anterior

31.94

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Smith & Nephew PLC ADR Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 abr 2026, 00:00 UTC

Ganancias

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 abr 2026, 00:00 UTC

Ganancias

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 abr 2026, 23:47 UTC

Charlas de Mercado

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 abr 2026, 23:43 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 abr 2026, 23:43 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

23 abr 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 abr 2026, 23:13 UTC

Adquisiciones, fusiones, absorciones

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 abr 2026, 22:33 UTC

Ganancias

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 abr 2026, 22:17 UTC

Ganancias

PLS Executed Offtake Agreement With Ronbay

23 abr 2026, 22:17 UTC

Ganancias

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 abr 2026, 22:16 UTC

Ganancias

PLS Commences Commissioning of Midstream Demonstration Plant

23 abr 2026, 22:15 UTC

Ganancias

PLS Group Reaffirms FY26 Guidance for All Metrics

23 abr 2026, 22:14 UTC

Ganancias

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 abr 2026, 22:14 UTC

Ganancias

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 abr 2026, 22:13 UTC

Ganancias

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 abr 2026, 22:12 UTC

Ganancias

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 abr 2026, 22:12 UTC

Ganancias

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 abr 2026, 22:11 UTC

Ganancias

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 abr 2026, 22:10 UTC

Ganancias

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 abr 2026, 22:09 UTC

Ganancias

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 abr 2026, 22:08 UTC

Ganancias

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 abr 2026, 22:04 UTC

Ganancias

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 abr 2026, 21:56 UTC

Charlas de Mercado
Ganancias

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 abr 2026, 21:48 UTC

Adquisiciones, fusiones, absorciones

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 abr 2026, 21:27 UTC

Ganancias

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 abr 2026, 21:25 UTC

Ganancias

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 abr 2026, 21:24 UTC

Ganancias

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 abr 2026, 21:24 UTC

Ganancias

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 abr 2026, 21:21 UTC

Ganancias

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 abr 2026, 21:21 UTC

Ganancias

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparación entre iguales

Cambio de precio

Smith & Nephew PLC ADR previsión

Precio Objetivo

By TipRanks

6.9% repunte

Estimación a 12 Meses

Media 35 USD  6.9%

Máximo 35 USD

Mínimo 35 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Smith & Nephew PLC ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

1 ratings

0

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

26.64 / 28.37Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat